Stem cell-based interventions for the prevention of morbidity and mortality following hypoxic-ischaemic encephalopathy in newborn infants.

CONCLUSIONS: There is currently no evidence from randomised trials that assesses the benefit or harms of stem cell-based interventions for the prevention of morbidity and mortality following hypoxic-ischaemic encephalopathy in newborn infants. PMID: 32813884 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32813884?dopt=Abstract

Source: Cochrane Database of Systematic Reviews - August 18, 2020 Category: General Medicine Authors: Bruschettini M, Romantsik O, Moreira A, Ley D, Thébaud B Tags: Cochrane Database Syst Rev Source Type: research